阿尔茨海默病风险因子APOE4对女性骨产生双形效应
bioRxiv : the preprint server for biology
|November 24, 2025
概括
阿尔茨海默病 (AD) 和骨质疏松症之间存在联系. 特别是APOE4蛋白质通过破坏骨细胞维护,导致女性骨脆弱,这表明它是认知和骨健康治疗的目标.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 整形外科 整形外科 整形外科
背景情况:
- 阿尔茨海默病 (AD) 与骨折风险增加有关,骨质疏松症预测女性的AD.
- 连接认知和骨健康下降的机制尚未完全理解.
- 与神经系统疾病相关的蛋白质,包括阿波利波蛋白E (ApoE),在老年骨中发现.
研究的目的:
- 调查APOE变体在骨和认知健康中的作用.
- 了解APOE4对骨和海马体的性别特异性影响.
- 确定将APOE4与骨脆弱性和认知衰退联系起来的分子机制.
主要方法:
- 来自老老小鼠的皮层骨的蛋白质组分析.
- 使用了人性化的APOE敲入小鼠模型 (APOE2,APOE3,APOE4).
- 分析了同一个小鼠的骨和海马体,重点关注性别特异性的影响.
主要成果:
- APOE4对骨转录组和蛋白质组表现出强烈的性别特异性影响,在女性中比在海马中更明显.
- 在女性中,APOE4蛋白因抑制骨细胞 perilacunocanalicular 重塑而导致骨脆弱.
- 骨细胞对ApoE的表达在老年女性骨中高于年轻或男性骨.
结论:
- APOE4 破坏骨质细胞维护骨质,不成比例地影响女性.
- 骨细胞是早期诊断认知障碍和治疗女性骨脆弱性的潜在目标.
- 研究结果强调了APOE基因型,性别和老化中的骨健康之间的联系.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.5K
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
993
相关概念视频
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
